Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$26.88 - $83.49 $1.2 Million - $3.72 Million
44,612 New
44,612 $3.72 Million
Q2 2022

Aug 12, 2022

BUY
$33.93 - $48.92 $491,204 - $708,214
14,477 Added 15.96%
105,202 $4.13 Million
Q1 2022

May 13, 2022

SELL
$29.74 - $46.0 $2.02 Million - $3.12 Million
-67,767 Reduced 42.76%
90,725 $3.34 Million
Q4 2021

Feb 11, 2022

BUY
$34.35 - $46.38 $1.55 Million - $2.09 Million
45,065 Added 39.73%
158,492 $7.22 Million
Q3 2021

Nov 12, 2021

BUY
$18.54 - $35.74 $2.1 Million - $4.05 Million
113,427 New
113,427 $4.05 Million
Q4 2020

Feb 11, 2021

SELL
$15.26 - $28.61 $689,523 - $1.29 Million
-45,185 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$20.58 - $28.96 $633,349 - $891,244
-30,775 Reduced 40.51%
45,185 $978,000
Q2 2020

Aug 13, 2020

BUY
$11.15 - $24.64 $846,954 - $1.87 Million
75,960 New
75,960 $1.79 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.03B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.